Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, “How AI is Transforming the Biopharmaceutical Value Chain from Discovery to
The international success of GLP-1 agonists for weight loss is overwhelming pharma safety operations as they strive to monitor incoming adverse events, says Daniel O’keeffe
European Pharmaceutical Manufacturer spotlights Daniel O’Keeffe of Qinecsa Solutions in a recent article examining whether patient outcomes are being compromised by fragmented and inconsistent safety
In today’s increasingly complex pharmacovigilance landscape, organizations are re-evaluating how they structure their safety operations to remain compliant, agile, and future ready. Join safety expert
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she explains how AI could revolutionize pharmacovigilance, if data, trust,
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she saw 2025 as an AI superposition in which pharmacovigilence
Qinecsa Chief Operating Officer, John Cogan, has been featured in The Pharma Navigator latest issue, where he discusses trends from 2025 for the bio/pharma industry.
Qinecsa VP, Product Management Reportum, Daniel O’Keeffe, has been featured in PharmaTimes Magazine latest issue, where he discusses how AI alone won’t solve pharma’s fragmented
Qinecsa Chief Operating Officer, John Cogan, has been featured in International Pharmaceutical Industry latest issue, where he predicts industry trends for the year ahead and
